Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset Contribution Agreement (the "Agreement") with Geron Corporation ...
BioTime, Inc.BTX was a big mover last session, as the company saw its shares rise above 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
BioTime completes expected acquisition of Asterias. Shares move 7% higher as BioTime broadens pipeline. Top management and a promising clinical program make BTX attractive. Shares of BioTime, Inc.
BioTime, Inc. BTX was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results